Preliminary results from the first six patients taking part in a Phase One trial surprised and delighted the Oxford University team.
Although the trial was only designed to test safety and dosages, two men with relatively advanced disease experienced dramatic improvements to their eyesight.
The researchers are now planning a larger Phase II trial that will focus on the therapy's effectiveness.
More top news
Syrian refugee children have been making clothes for British shoppers, it has been claimed.
A judgement is due on Monday on a Christian bakery’s appeal against a ruling that found them guilty of discrimination against a gay man.
The crash happened at about 7.20am local time as the plane was heading for Misrata in Libya.